ArticleCell death discovery2024

Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans.

Kirti S Prabhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.